FibroGen Inc
F:1FG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
FibroGen Inc
F:1FG
|
US |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XMUN:AUS
|
AT |
|
G
|
goeasy Ltd
F:1ES
|
CA |
|
Intershop Holding AG
SIX:ISN
|
CH |
|
B
|
Bank Handlowy w Warszawie SA
SWB:6HW
|
PL |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
S
|
SPAR Group Ltd
XBER:S8A
|
ZA |
|
C
|
Community Health Systems Inc
XMUN:CG5
|
US |
|
Hanjaya Mandala Sampoerna Tbk PT
F:HSZ
|
ID |
|
Schibsted ASA
F:XPGB
|
NO |
|
R
|
Rentokil Initial PLC
DUS:RTO1
|
UK |
|
Q
|
Qiagen NV
XHAM:QIA
|
NL |
|
Konami Group Corp
F:KOA0
|
JP |
|
H
|
Hong Kong and China Gas Co Ltd
XHAM:HCG
|
HK |
Bankruptcy Probability
FibroGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
FibroGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
441.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
FibroGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, FibroGen Inc has total debt of 19.5m USD. This includes both short-term (0 USD) and long-term (19.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
